Chinese Journal of Inflammatory Bowel Diseases 2020;04(2):142-145

doi:10.3760/cma.j.cn101480-20190519-00073

Risks of new onset and recurrence of tumors in inflammatory bowel disease patients receiving anti-TNF agents

Mengshi CHEN 1 ; Xiaocang CAO

Affiliations

+expand

Keywords

Inflammatory bowel diseases; Anti-TNF agents; Tumor; Risk

Country

China

Language

Chinese

Abstract

The risks of tumors in patients with inflammatory bowel disease (IBD) are significantly higher than that in normal people. It is still obscure whether anti-tumor necrosis factor (anti-TNF) agents increase the risks of malignant tumors in these patients and whether the patients with previous history of malignant tumors could use anti-TNF agents. It becomes an important issue for making clinical decisions.